Histone Deacetylase Inhibitors [MoA] - N0000175071

Pharmacologic Class Information

Pharmacologic Code N0000175071
Pharmacologic Name Histone Deacetylase Inhibitors
Pharmacologic Uses
  • histone deacetylase (HDAC) inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Histone Deacetylase Inhibitors

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Histone Deacetylase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-0568Zolinza Non-Proprietary Name: VorinostatCapsuleOralMerck Sharp & Dohme LlcACTIVE
0703-4004Romidepsin Non-Proprietary Name: RomidepsinInjection, Solution, ConcentrateIntravenousTeva Parenteral Medicines, Inc.ACTIVE
72893-002Beleodaq Non-Proprietary Name: BelinostatInjection, Powder, Lyophilized, For SolutionIntravenousAcrotech Biopharma IncACTIVE